Gene Panel Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028. Increase in cancer research and rise in demand of genetic testing are key drivers for Global Gene Panel Market.
Gene panel testing refers to sequencing multiple pre-specified genes using NGS sequencing platforms. Accelerated development of multigene test panels is having a positive impact on the medical conduct and individualized treatment for patients. According to the International Agency for Research on Cancer, by 2030 there will be over 22 million new cases a year, up from 14 million in 2012. There is a significant rise in prevalence of cancer globally. So, during the study of Global Gene Panel market, we have considered Gene Panel products and consumables to analyze the market.
Global Gene Panel Market report is segmented on the basis of Product type, Approach type, Application Type, End User type and by regional & country level. Based on Product type global Gene Panel Market is classified as Kits and Services. Based upon approach, global Gene Panel Market is classified as Amplicon based and Hybridization based. Based upon Sample type, global Gene Panel Market is classified as Blood, Urine, Serum/Plasma and others. Based upon Application type, global Gene Panel Market is classified as Cancer Risk Assessment, Diagnosis of Congenital Diseases and Others. Based upon End User type, global Gene Panel Market is classified as Hospitals, Diagnostic Laboratories and Research & Academic Institutes.
The regions covered in this Gene Panel Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Gene Panel is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
By Regional & Country Analysis
North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Growing awareness about the potential benefits in genetic testing, increasing number of cancer patients, growing research in cancer and other congenital diseases, rising demand for targeted approaches and personalized medicine are the major key drivers for the growth of the Global Gene Panel Market. However, high costs serious doubts among individuals concerning the authenticity of genetic reports are the major restrains of the Global Gene Panel Market. Nonetheless, untapped market and technological advancements may generate new opportunities in forecast period.
North America dominates the market with highest market share due to increasing number of cancer incidences, increasing launch of new and advanced products, government support for genomics research, presence of leading Next Generation Sequencing providers and growing research on cancer. In 2016, total U.S. medical and health Research & Development spending was $171.8 billion .According to NCI (National Cancer Institute), in 2016, there were an estimated 15.5 million cancer survivors in the United States and is expected to increase to 20.3 million by 2026. Europe is the second largest market for Gene Panel Testing. According to the latest report by World Health Organization (WHO), with more than 3.7 million new cases and 1.9 million deaths each year, cancer represents the second most important cause of death and morbidity in Europe. Increasing prevalence of cancer and increased growth in research and development activities are majorly responsible on growth of Gene Panel market in Europe. According to the latest report by World Health Organization (WHO), Asia Pacific region anticipates to see a 70% increase in new cancer cases in the next two decades. Asia Pacific Gene Panel Market is witnessed with strong growth rate majorly due high prevalence of cancer, increasing population, growing awareness regarding cure and treatment of cancer and government funding for research and development. India and China are potential markets for genetic services, due to increase in the prevalence of infectious diseases.
|Forecast Period||2022 - 2028|
|Market Size in 2020:||XX|
|Base year considered||2021|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||XX|
|Tables, Charts & Figures:||175|
Gene Panel manufacturers
|Illumina, Inc,Thermo Fisher Scientific,Agilent Technologies,Qiagen,BGI,Eurofins Scientific,F. Hoffmann-La Roche Ag,Integrated Dna Technologies,GATC Biotech Ag,Genewiz, Inc.,Novogene Corporation,Personali,Archerdx,Genedx,Centogene Ag,Oxford Gene Technology,Primbio Research Institute,Fulgent Genetics,Gene Dx,Blueprint Genetics,Invitae Corporation|
|Segments Covered||By Product type Analysis, By Approach analysis, By Application analysis|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2023-24 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®